mTOR inhibitors
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for mTOR inhibitors, covering 2023-05-25 to 2025-09-15. Get the full timeline:
Most recent: Clinical Trial Update: A Phase Ib/II Study of QLC1401 Combined With CDK4/6 or mTOR Inhibitors in ER+/HER2- Advanced Breast Cancer [Phase 1, Phase 2]